CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Viridian Therapeutics - CapyFin

Viridian Therapeutics

VRDN · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $72K

Previous year: -$0.79

Weighted-average common shares outstanding

Previous year: 61.1M

Research and development expenses

Previous year: $40.9M

General and administrative expenses

Previous year: $15M

Cash and Equivalents

Previous year: $613M

Previous year: $630M

Viridian Therapeutics

Unlock previous datapoints

Viridian Therapeutics

Unlock previous datapoints

Viridian Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue - related party Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...